Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

MERCK AND COMPANY (MRK)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Business Summary
Logo Merck and Company
Discovers, develops and markets human and animal health products

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.

It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.

The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as vaccines, which it sells to veterinarians, distributors, and animal producers.

The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients.

The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Number of employees : 69 000 persons.
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
Pharmaceutical35,15189%35,39088.5% +0.68%
Other Segment3,8629.8%4,27210.7% +10.62%
Other794.002%460.001.2% -42.07%
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States18,47846.8%17,42443.6% -5.7%
Europe, Middle East and Africa10,95327.7%11,47828.7% +4.79%
Asia Pacific3,9189.9%4,33710.8% +10.69%
Japan2,8467.2%3,1227.8% +9.7%
Latin America2,1555.5%2,3395.9% +8.54%
Other1,4573.7%1,4223.6% -2.4%
Managers
NameAgeSinceTitle
Kenneth Frazier631992Chairman, President & Chief Executive Officer
Robert M. Davis, MBA512014CFO & Executive Vice President-Global Services
Thomas Henry Glocer592007Independent Director
Rochelle B. Lazarus, MBA702004Independent Director
Leslie Brun662008Lead Independent Director
Carlos Eduardo Represas de Almeida722009Independent Director
Patricia Fiorello Russo651995Independent Director
Craig B. Thompson, MD652008Independent Director
Wendell Weeks582004Independent Director
Peter C. Wendell, MBA672003Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 3,574,926,037 2,688,512,274 75.2% 884,622,139 24.7% 75.2%
Shareholders
NameEquities%
The Vanguard Group, Inc. 194,730,046 7.24%
BlackRock Fund Advisors 129,927,256 4.83%
SSgA Funds Management, Inc. 112,130,981 4.17%
Capital Research & Management Co. (World Investors) 89,709,295 3.33%
Wellington Management Co. LLP 76,042,840 2.83%
T. Rowe Price Associates, Inc. 41,198,302 1.53%
Northern Trust Investments, Inc. 33,318,753 1.24%
Geode Capital Management LLC 30,380,753 1.13%
Norges Bank Investment Management 28,509,598 1.06%
Franklin Advisers, Inc. 23,710,856 0.88%
Holdings
NameEquities%Valuation
Menlo Therapeutics Inc (MNLO) 1,243,1685.41%10,405,316 USD
Kalvista Pharmaceuticals Inc (KALV) 1,070,5899.93%9,282,007 USD
OpGen Inc (OPGN) 216,5383.63%463,391 USD
Markets and indexes
- NYSE
- Main Market
- CAC International 25 / DJIA, SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  MRK:US
- Reuters Code :  MRK.N
- Datastream Code :  U:MRK
Company contact information
Merck and Company
2000 Road Galloping Hill
PO Box 100
NJ 07033 Kenilworth, New Jersey
États-Unis (les)

Phone : +1 908 423 1000
Fax : +1 908 735 1253
Internet : http://www.merck.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MERCK AND COMPANY8.90%165 373
JOHNSON & JOHNSON-12.27%329 475
PFIZER0.22%213 568
NOVARTIS-9.42%191 991
ROCHE HOLDING LTD.-12.58%191 785
AMGEN6.47%122 515
ABBOTT LABORATORIES8.53%108 592
BAYER-5.82%107 415
GLAXOSMITHKLINE16.90%101 693
SANOFI-3.95%98 556
ELI LILLY AND COMPANY1.91%93 260
BRISTOL-MYERS SQUIBB COMPANY-12.47%90 128
NOVO NORDISK A/S-10.01%90 023
ASTRAZENECA2.11%87 758
ALLERGAN PLC5.45%58 800
CELGENE CORPORATION-24.49%57 116
SHIRE4.26%49 241
JIANGSU HENGRUI MEDICINE CO LTD48.83%44 721
TAKEDA PHARMACEUTICAL CO LTD-31.26%32 272
ASTELLAS PHARMA INC21.24%31 635
CHUGAI PHARMACEUTICAL CO LTD4.33%30 624
Connections : Merck and Company
American Bar Association
The Conference Board, Inc.
Rush University Medical Center
Schweizerische Rückversicherungs-Gesellschaft AG
The International Business Council
American Society for Clinical Investigation
The Cleveland Clinic Foundation
Bombardier Mexico SA de CV
Verto Analytics, Inc.
Pharmaceutical Research & Manufacturers of America
Gambro AB
The Pennsylvania State University
Verto Analytics Oy
The Committee of 200
K2 Intelligence, Inc.
NXT Capital LLC
Atlantic Council
National Institute of Genomic Medicine
Supreme Court of the United States
Weill Cornell Medical College
New York State Bar Association
Arconic Defense, Inc.
Yale University
The Society of Memorial Sloan-Kettering Cancer Center
Forum Mondial de L'Economie
National Academy of Sciences
The Library of Congress (District of Columbia)
AdvaMedDx
European Business Leaders' Convention
SARR Group LLC
Angelic Ventures LP
The American Law Institute
G100 Cos.
NewYork-Presbyterian Hospital
Council on Foreign Relations, Inc.
The Partnership for New York City
Fundacion Mexicana Para La Salud AC
Lincoln Center for the Performing Arts, Inc.
Latin American Business Council
President's Export Council
KKR Management LLC
Lehigh University
Cornerstone Christian Academy
Corning, Inc. Foundation
The Economic Club of New York
Exploratorium
Memorial Sloan-Kettering Cancer Center
American Academy of Arts & Sciences
Charles River Laboratories, Inc.
Columbia Business School
American Association for Cancer Research
Direct Marketing Association, Inc.
Institute of Medicine
Advertising Women of New York
American Association of Physicists In Medicine
World Wildlife Fund, Inc.
CMI Marketing, Inc.
Committee Encouraging Corporate Philanthropy
The Corning Museum of Glass
United States Defense Business Board
ARTstor, Inc.
Women's Forum, Inc.
Sierra Ventures, Inc.
Official Publications
05/25Report 
05/24SEC Filing 8K 
05/15Report 
© 2018 People , Fundamentals and Ownership    © 2018 Cofisem